Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
07/2005
07/28/2005US20050165063 Amine compounds and use thereof
07/28/2005US20050165018 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology
07/28/2005US20050164963 Components for producing amphoteric liposomes
07/28/2005CA2547696A1 Malononitrile compounds and use thereof
07/27/2005EP1557181A1 Vapor sterilization using a non-aqueous source of hydrogen peroxide
07/27/2005EP1556445A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
07/27/2005EP1556390A2 Functionalized ionic liquids, and methods of use thereof
07/27/2005EP1556035A2 Novel aromatic compounds possessing antifungal or antibacterial activity
07/27/2005EP1556029A2 Thiomolybdate analogues and uses thereof
07/27/2005EP1387837B1 Novel azole or triazole derivatives, method for preparing same and use thereof as antifungal medicines
07/27/2005EP1254075A4 Nonaborate compositions and their preparation
07/27/2005EP1250335B1 Process and intermediates for the preparation of imidazopyridines
07/27/2005EP1185527B1 1-(p-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for the production and the utilization thereof and pharmaceutical preparations containing said compounds
07/27/2005CN1646546A Method for the production of bis(perfluoroalkyl)phosphinic acids and the salts thereof
07/27/2005CN1646545A Method for the production of monohydro-perfluoroalkanes, bis(perfluoroalkyl)phosphinates, and perfluoroalkylphosphonates
07/27/2005CN1646540A Functionalized ionic liquids, and methods of use thereof
07/27/2005CN1646516A Imidazolinylmethyl aralkylsulfonamides
07/27/2005CN1646498A Novel crystal form of 5-hydroxy-1-methylhydantoin
07/27/2005CN1646497A New aryl imidazoles and related compounds as C5a receptor modulators
07/27/2005CN1646496A Novel tricycloimidazoline derivatives, method for production and use thereof as medicaments
07/27/2005CN1646495A Amine compounds and use thereof
07/27/2005CN1646492A Chain oligolactic acid thioester
07/27/2005CN1644585A Covalently linked oligonucleotide minor grove binder conjugates
07/27/2005CN1212311C Acrylonitrile compounds, process for their prodn, and pesticides containing them
07/27/2005CN1212117C Medicine composition for treating diabetes mellitus
07/26/2005US6921767 Such as (2-(4-(3-(1,4,5,6-Tetrahydropyrimidin-2-ylamino)prop oxy)phenyl) -cyclopropyl)acetic acid; for treating angiogenesis/osteoporosis/ humoral hypercalcemia/smooth muscle cell migration/atherosclerosis/arthritis
07/26/2005US6921760 Psychotherapeutic agents.
07/21/2005WO2005066145A1 Heteroaryl-ureas and their use as glucokinase activators
07/21/2005WO2005066140A1 3-hydroxymethyl-4-hydroxy-phenyl derivatives for the treatment of respiratory illnesses
07/21/2005WO2005066137A1 2,5-diaryl-1h-imidazole-4-carboxamides as neurokinin-3 receptor modulators for the treatment of central nervous system and peripheral diseases
07/21/2005WO2005065681A1 N- hydroxy-3-(3-(1h-imidazol-2-yl)-phenyl)-acrylamide derivatives and related compounds as histone deacetylase (hdac) inhibitors for the treatment of cancer
07/21/2005WO2005033119A9 Supramolecular compounds and their use as antitumour and antiviral agents
07/21/2005US20050159470 Histone deacetylase inhibitors
07/21/2005US20050159468 Drugs for antiproliferation agent for pyrrolidine compounds
07/21/2005US20050159460 2-[(1R,3S,4S)-1-benzyl-4-t-butoxycarbonylamino-3-hydroxy-5-phenylpentyl]-5-butyl-thiazole; for inhibiting beta-secretase-mediated cleavage of amyloid precursor protein, particularly to inhibit production of A beta peptide; treatment of diseases associated with a pathological form of A beta peptide
07/21/2005US20050159430 Administering 1-(2-(4-(3-trifluoromethyl-phenyl)piperazin-1-yl) ethyl)-2,3-dihydro-1H-benzimidazol-2-one (flibanserin); serotonin receptor antagonists; useful for treating psychological and nervous system disorders, Parkinson's disease
07/21/2005US20050159427 N-acylsulfonamide apoptosis promoters
07/21/2005DE10359797A1 Verfahren zur Herstellung von N,N'-Carbonyldiazolen A process for the preparation of N, N'-carbonyldiazoles
07/21/2005DE10359026A1 Verfahren zur Herstellung von Tetrahydrogeranylaceton A process for preparing tetrahydrogeranylacetone
07/20/2005EP1554253A1 Imidazolium cxcr3 inhibitors
07/20/2005EP1554252A1 Hexaarylbiimidazole compounds and photopolymerization initiator compositions containing the same
07/20/2005EP1554239A2 Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
07/20/2005EP1554238A2 Ionic liquids containing a sulfonate anion
07/20/2005EP1268396B1 Diphenyl ether compounds useful in therapy
07/20/2005CN1642931A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
07/20/2005CN1642535A Tuberculosis treatment using pleuromutilin derivatives
07/20/2005CN1211371C Single imidazole/multiamine acylamide kind compound and its synthesis method and use
07/20/2005CN1211370C Biphenylsulfonyl-substd. imidazole derivs., their preparation process, their use as drug or diagnostic agent
07/20/2005CN1211367C Prostaglandin agonists and their use to treat bone disorders
07/19/2005US6919380 Carbocyclic esters such as 5-chloro-2-methanesulfonylindan-1--yl-4-chlorobenzoate, used as anorexigenic agents; dietetics
07/19/2005US6919367 Substituted thioacetamides
07/19/2005US6919365 Also oxazolidinediones; excellant enzyme inhibitors of chymase and/or tryptase; antiallergens; antiinflammatory agents; vascular circulatory system disease; vision defects, antidiabetic and -arthritic agents; pancreatitis; hepatitis
07/19/2005US6919357 Human sexual disorders; therapy for impotency
07/19/2005US6919036 Reacting borate with guanidinium or imidazolidinium compound; heating; crystal structure; forming ceramic; fire retarders, microbiocide
07/14/2005WO2005064008A1 Method and compositions for identifying anti-hiv therapeutic compounds
07/14/2005WO2005063718A1 Method for the production of n,n -carbonyldiazoles
07/14/2005WO2005063717A1 An improved process for the preparation of zoledronic acid
07/14/2005WO2005063716A1 Imidazoles and their use cck-1 receptor modulators
07/14/2005WO2005063705A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions
07/14/2005WO2005063689A1 Benzamide derivative
07/14/2005WO2005063661A1 Fluorinating agent and method for producing fluorine-containing compound using same
07/14/2005WO2005063247A1 Aryl sulfonamide compounds and uses related thereto
07/14/2005WO2005063241A1 Preventive and/or therapeutic agent for disease in which mitochondrial benzodiazepine receptor participates
07/14/2005WO2005023198A3 Modafinil compositions
07/14/2005WO2004082585A3 Water-soluble conjugates of phenytoin
07/14/2005US20050154232 Nitrosation of the diphenylamine with an alkali metal nitrite in an acidic medium; the nitrosodiphenylamines increase the bioavailability of endothelial nitrogen monoxide; the diphenylamines are used as antioxidants and free radical scavengers; insulin resistance
07/14/2005US20050154205 Complexes of N-heterocyclic carbenes and the use thereof
07/14/2005US20050154202 Substituted aryl amides
07/14/2005US20050154195 Reacting an amine compound with alcoholate in presence of solvent
07/14/2005US20050154056 Inhibitors of HCV NS5B polymerase
07/14/2005US20050154028 1-(3-Fluoro-phenyl)-3-[4-methoxy-3-(2-piperidin-1-yl-ethoxy)-phenyl]-imidazolidin-2-one; serotonin 5-ht2c receptor antagonist; antidepressant and anxiolytic agent
07/14/2005US20050154011 such as S)-3-Methylcarbamoyl-7-sulfoamino-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester, used in the treatment of protein tyrosine phosphatase (PTPase) mediated disorder such as diabetes
07/14/2005US20050153996 Compounds that modulate ppar activity and methods for their preparation
07/14/2005US20050153968 Monocyclic N-aryl hydantoin modulators of androgen receptor function
07/14/2005US20050153958 Substituted aryl ketones
07/14/2005CA2552393A1 Method for the production of n,n-carbonyldiazoles
07/14/2005CA2550730A1 Method and compositions for identifying anti-hiv therapeutic compounds
07/14/2005CA2548309A1 Aryl sulfonamide compounds and uses related thereto
07/13/2005EP1553088A1 1-substituted 4-nitroimidazole compound and process for producing the same
07/13/2005EP1551826A1 Hydantoine derivatives and their use as tace inhibitors
07/13/2005EP1551810A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect
07/13/2005EP1551799A1 Cyclohexyl sulphones as gamma-secretase inhibitors
07/13/2005EP1551797A1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
07/13/2005EP1178969B1 Gastrin and cholecystokinin receptor ligands
07/13/2005EP1161415B1 N-cyanomethylamides as protease inhibitors
07/13/2005EP0949249B1 Process for producing imidazole derivatives
07/13/2005CN1639312A Immidazoline quats
07/13/2005CN1639266A Process for the preparation of cationic azo compounds
07/13/2005CN1639130A Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
07/13/2005CN1639129A Halogen-free ionic liquids
07/13/2005CN1639126A Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
07/13/2005CN1639109A Dynamic resolution of isomers and resolved isomers
07/13/2005CN1639096A Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative
07/13/2005CN1638757A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin
07/13/2005CN1636986A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636985A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636984A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636976A Mutilin derivatives and their use as antibacterials
07/13/2005CN1636975A Process for the preparation of methionine from hydrotrope of methionine alkali metal salt
07/13/2005CN1636967A Noval compounds, their use and preparation